Rhetoric Meets Reality: A Timeline Of Trump's First 100 Days

President Trump is empty-handed on health care victories so far, as initial health reform repeal efforts collapsed and the shock value of drug pricing tweets wore off. But some actions may evolve into biopharma impact further down the road.

White House

Supporters of President Donald Trump's health care pledges might be particularly vexed at the traditional benchmark of assessing the first 100 days in office for a new US president.

His early inflammatory comments on drug pricing controls sparked negative Wall Street reaction. But as he filled in his circle...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership